Internal radiation therapy: a neglected aspect of nuclear medicine in the molecular era |
| |
| Authors: | Yansong Lin |
| |
| Affiliation: | Department of Nuclear Medicine, Peking Union Medical College Hospital, Beijing 100730, China |
| |
| Abstract: | With increasing evidence, internal radiation therapy, also known as brachytherapy, has become a neglected aspect of nuclear medicine in the molecular era. In this paper, recent developments regarding internal radiation therapy, including developments in radioiodine-131 (131I) and thyroid, radioimmunotherapy (RIT) for non-Hodgkin lymphoma (NHL), and radiopharmaceuticals for bone metastases. Relevant differences and status of their applications in China were mentioned as well. These molecular mediated internal radiation therapies are gaining increasing importance by providing palliative and curative treatments for an increasing number of diseases and becoming one of the important parts of molecular nuclear medicine. |
| |
| Keywords: | brachytherapy radioisotope neoplasm radioiodine hyperthyroidism |
|
| 点击此处可从《生物医学研究杂志》浏览原始摘要信息 |
|
点击此处可从《生物医学研究杂志》下载免费的PDF全文 |
|
